Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study

[1]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[2]  Bryan Langholz,et al.  Selecting Controls for Assessing Interaction in Nested Case-control Studies , 2003, Journal of epidemiology.

[3]  A. Børresen-Dale,et al.  Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.

[4]  Erik Holmberg,et al.  Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts , 2002, Radiation research.

[5]  D. Purdie,et al.  Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer , 2002, Nature Genetics.

[6]  Katherine L Kahn,et al.  Validity of cancer registry data for measuring the quality of breast cancer care. , 2002, Journal of the National Cancer Institute.

[7]  P. Brennan,et al.  Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? , 2002, Carcinogenesis.

[8]  J. Sambrook,et al.  Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.

[9]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[10]  T. Dörk,et al.  Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. , 2001, Cancer research.

[11]  E. Ostrander,et al.  Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history , 2001, Cancer.

[12]  C B Begg,et al.  The search for cancer risk factors: when can we stop looking? , 2001, American journal of public health.

[13]  B Langholz,et al.  Counter-matching in studies of gene-environment interaction: efficiency and feasibility. , 2001, American journal of epidemiology.

[14]  Sara G. Becker-Catania,et al.  The pathogenesis of ataxia-telangiectasia , 2001, Clinical reviews in allergy & immunology.

[15]  K. Buetow,et al.  The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. , 2001, Biochimica et biophysica acta.

[16]  H. Piwnica-Worms,et al.  Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. , 2000, Cancer research.

[17]  E. Hall.  Radiation, the two-edged sword: cancer risks at high and low doses. , 2000, Cancer journal.

[18]  A. Blasina,et al.  Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1 , 2000, Nature Cell Biology.

[19]  S. Elledge,et al.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Gatei,et al.  Role for ATM in DNA damage-induced phosphorylation of BRCA1. , 2000, Cancer research.

[21]  M Huberman,et al.  Application of the missing-indicator method in matched case-control studies with incomplete data. , 1999, American journal of epidemiology.

[22]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[23]  M. Little,et al.  Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. , 1999, Radiation research.

[24]  T. Murray.  Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. , 1998, Survey of ophthalmology.

[25]  M. Little,et al.  Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. IV. Prediction of risks in relatives of cancer-predisposed individuals. , 1998, Radiation research.

[26]  C. Begg,et al.  A note on the estimation of relative risks of rare genetic susceptibility markers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  G R Howe,et al.  Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. , 1995, Radiation research.

[28]  Bryan Langholz,et al.  Counter-matching: A stratified nested case-control sampling method , 1995 .

[29]  D Clayton,et al.  Sampling strategies in nested case-control studies. , 1994, Environmental health perspectives.

[30]  R. A. Johnson,et al.  Data on Prior Pesticide Use Collected from Self‐and Proxy Respondents , 1993, Epidemiology.

[31]  M. Blettner,et al.  Cancer in the contralateral breast after radiotherapy for breast cancer. , 1992, The New England journal of medicine.

[32]  S. Friend,et al.  Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.

[33]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[34]  D. Preston,et al.  Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. , 1991, Radiation research.

[35]  F. Krasin,et al.  Comparison of contralateral breast doses from 1/2 beam block and isocentric treatment techniques for patients treated with primary breast irradiation with 60CO. , 1989, International journal of radiation oncology, biology, physics.

[36]  M. Swift,et al.  Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.

[37]  B. Pasternack,et al.  Breast cancer among women given X-ray therapy for acute postpartum mastitis. , 1986, Journal of the National Cancer Institute.

[38]  Thompson Wd.  Methodologic perspectives on the study of multiple primary cancers , 1986 .

[39]  A. Coldman,et al.  Radiation dose and second breast cancer. , 1985, British Journal of Cancer.

[40]  P. Roberson,et al.  Dose to the contralateral breast due to primary breast irradiation. , 1985, International journal of radiation oncology, biology, physics.

[41]  A. Whittemore,et al.  Environmental Epidemiology: Risk Assessment. , 1984 .

[42]  J H Lubin,et al.  Biased selection of controls for case-control analyses of cohort studies. , 1984, Biometrics.

[43]  D. Thomas,et al.  Biological models and statistical interactions: an example from multistage carcinogenesis. , 1981, International journal of epidemiology.

[44]  L. Strong,et al.  Bone sarcoma as a second malignant neoplasm in children: Influence of radiation and genetic predisposition , 1980, Cancer.

[45]  L. Strong.  Genetic and environmental interactions , 1977, Cancer.

[46]  M. Kastan,et al.  ATM--a key determinant of multiple cellular responses to irradiation. , 2001, Acta oncologica.

[47]  Bryan Langholz,et al.  Risk set sampling in epidemiologic cohort studies , 1996 .

[48]  J L Kelsey,et al.  Radiation and other environmental exposures and breast cancer. , 1993, Epidemiologic reviews.

[49]  L. Pierce,et al.  Cancer in the contralateral breast after radiotherapy for breast cancer. , 1992, The New England journal of medicine.

[50]  W. Thompson,et al.  Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut Tumor Registry. , 1987, Journal of chronic diseases.

[51]  J. Robins,et al.  More on "Biased selection of controls for case-control analyses of cohort studies". , 1986, Biometrics.

[52]  W. Thompson,et al.  Methodologic perspectives on the study of multiple primary cancers. , 1986, The Yale journal of biology and medicine.

[53]  J. Towers,et al.  What is Gorlin's syndrome? The diagnosis and management of the basal cell naevus syndrome, based on a study of thirty-seven patients. , 1977, British journal of plastic surgery.